ReviewBritish journal of cancer2022

ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges.

Sarah K Herzog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.